W. El-Deiry

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

D Andrews, R A Knight, G Melino, 2014, Cell Death and Differentiation.

Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.

T. Rebbeck, A. Gazdar, S. Powell, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.

W. El-Deiry, R. Meng, P. Phillips, 1999, International journal of oncology.

Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.

N. Spinner, D. Dicker, N. Ozören, 2000, International journal of oncology.